Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04839003

A Registry of AL Amyloidosis (ReAL)

A Registry to Investigate Real-world Natural History, Impact of Therapies and Patterns of Progression of AL Amyloidosis (ReAL)

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.

Detailed description

Thanks to this registry, it will be possible to collect data at diagnosis and during follow up, in order to be able to describe the natural history of AL amyloidosis in a real-world setting and to define and validate prognostic models, response and relapse criteria applicable at any point of the disease.

Conditions

Timeline

Start date
2020-02-27
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2021-04-09
Last updated
2026-04-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04839003. Inclusion in this directory is not an endorsement.